上海伊米诺康生物科技有限公司 Mediaroom - PR Newswire APAC

Search

上海伊米诺康生物科技有限公司

Latest News

Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse

BOSTON, July 17, 2024 /PRNewswire/ -- Immunocan announced the successful construction of new strain...

2024-07-17 21:50 1429

Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse

Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse

BOSTON, June 1, 2024 /PRNewswire/ -- Immunocan announces significant progress in the construction o...

2024-06-01 20:00 1490

Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse

Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

SHANGHAI, Dec. 13, 2023 /PRNewswire/ -- Shanghai Immunocan Biotech Co., Ltd. ("Immunocan") announce...

2023-12-13 22:00 1928